A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma
Clinical trial NCT00290706 · TERMINATED
Trial details
- NCT number
- NCT00290706
- Sponsor
- Northwestern University
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-07
- Primary completion
- 2011-02-11
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.